Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care

American Journal of Medical Quality

Volumn 22, Issue 5, 2007, Pages 327-333

  Ansell, Jack ^a   Caro, J Jaime ^b   Salas, Maribel ^b   Dolor, Rowena J ^c   Corbett, William ^d   Hudnut, Andrew ^e   Seyal, Saleem ^f   Lordan, Noreen D ^b   Proskorovsky, Irina ^b   Wygant, Gail ^g  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Caro Research Institute   (Canada)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d Med Ctr Ctrl Massachusetts U   (United States)

^e Sutter Institute for Medical Research   (United States)

^f Research Institute of Middle America

^g ASTRAZENECA   (United Kingdom)

Author keywords

Anticoagulation; Atrial fibrillation; Health care; INR; Routine medical care; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; VITAMIN K GROUP;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL TRIAL; DOCUMENTATION; FEMALE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; DOCUMENTATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VITAMIN K;

EID: 34548208102     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860607303003     Document Type: Article

References (26)

1. Albers GW, Atwood JE, Hirsh J., Sherman DG, Hughes RA, Connolly SJ Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med. 1991 ; 115: 727-736.
2. Wolf PA, Abbott RD, Kannel WB Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med. 1987 ; 147: 1561-1564.
3. SPAF-III Stroke Prevention in Atrial Fibrillation Investigators. Adjusted dose warfarin versus low intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet. 1996 ; 348: 633-638.
4. Petersen P., Grind M., Adler J., SPORTIF II Investigators. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: SPORTIF II-a dose-guiding, tolerability and safety study. J Am Coll Cardiol. 2002 ; 41: 1445-1451.
5. Halperin JL Efficacy and safety study of oral direct thrombin inhibitor ximelagatran compared with dose-adjusted warfarin in the prevention of stroke and systemic embolic events in patients with atrial fibrillation. SPORTIF V. Paper presented at the American Heart Association Scientific Sessions, November 2003, Orlando, FL.
6. Benavente O., Hart R., Koudstaal P., et al. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2000 ; 2: CD001927.
7. Green CJ, Hadorn DC, Bassett K., Kazanjian A. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. Can J Cardiol. 1997 ; 13: 811-815.
8. Laupacis A. Re: Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. Can J Cardiol. 1998 ; 14: 659, 662-663, 665.
9. Albers GW, Dalen JE, Laupacis A., et al. Antithrombotic therapy in atrial fibrillation. Chest. 2001 ; 119: 194S - 206S.
10. McCormick D., Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 2001 ; 161: 2458-2463.
11. Bradley BC, Perdue KS, Tisdel KA, Gilligan DM Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center. Am J Cardiol. 2000 ; 85 (5). 568-572.
12. Fang MC, Stafford RS, Ruskin JN, Singer DE National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004 ; 164: 55-60.
13. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000 ; 160: 41-46.
14. Staresinic AG, Sorkness CA, Goodman BM, Pigarelli DW Comparison of outcomes using two delivery models of anticoagulation care. Arch Intern Med. 2006 ; 166: 997-1002.
15. McCrory DC, Matchar DB, Samsa G., Sanders LL, Pritchett Elc. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995 ; 155: 277-281.
16. Samsa GP, Matchar DB Relationship between test frequency and outcomes of anticoagulation. J Thromb Thrombolysis. 2000 ; 9: 283-292.
17. Ansell J., Hollowell J., Pengo V., Martinez-Brotons F., Caro J., Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the International Study of Anticoagulation Management (ISAM). J Thromb Thrombolys. In press.
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993 ; 69: 236-239.
19. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring and patient self-management. Am Heart J. 1996 ; 132: 1095-1100.
20. Regier DA, Sunderji R., Lynd LD, Gin K., Marra CA Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ. 2006 ; 174: 1847-1852.
21. Ansell JE Anticoagulation management as a risk factor for adverse events: grounds for improvement. J Thromb Thrombolys. 1998 ; 5 (suppl): S13 - S18.
22. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A., Hylek E. The pharmacology and management of the vitamin K antagonists. Chest. 2004 ; 126 (suppl):202S-231S.22.
23. White RH, McBurnie MA, Manolio T., et al. Oral anticoagulation in patients with atrial fibrillation. Am J Med. 1999 ; 106: 165-171.
24. Gross CP, Vogel EW, Dhond A., et al. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Therapeut. 2003 ; 25: 1750-1764.
25. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001 ; 135: 703-710.
26. Garnick DW, Lawthers AG, Palmer RH, Moentmann SJ, Fowles J., Weiner JP A computerized system for reviewing medical records from physicians' offices. Jt Comm J Qual Improv. 1994 ; 20: 679-694.